Consolidated Water Co. Ltd. (CWCO) Balance Sheet

The steady increase in net PPE from $57.7M to $62.2M over ten quarters indicates ongoing investment in the utility's water infrastructure. However, this asset growth has been largely self-funded, with capex averaging a modest $2-3M per quarter, suggesting a gradual rather than transformative expansion of the rate base. The consistent level of PP&E relative to total assets indicates this remains the core of the company's regulated operations.

The equity base has grown from $192.1M in 2024Q1 to $225.6M in 2026Q2, a 17.4% increase driven by accumulated earnings rather than new equity issuance. This pattern suggests the company has not diluted shareholders through DRIP or ATM programs. While this provides exceptional balance sheet strength, the minimal leverage may also indicate the company is not utilizing the capital structure to optimize its cost of capital for regulated asset growth.

The near-zero leverage ratio stands in stark contrast to peer utilities like Middlesex Water (0.85 D/E) and York Water (0.97 D/E), suggesting CWCO's regulatory compact may not incentivize or permit meaningful debt financing. This capital structure provides enormous headroom for future borrowing but may also reflect regulatory constraints on authorized returns or limited growth opportunities. Investors should monitor whether this reflects prudent management or an inability to deploy capital at regulated returns.

The company's liquidity position has strengthened considerably, with cash reserves growing from $46.2M in 2024Q1 to $132.6M by 2026Q2. This cash accumulation appears to be funding ongoing capital needs rather than being deployed for shareholder returns or debt reduction. The strong liquidity provides a buffer against operational volatility but may also represent an inefficient use of capital if better investment opportunities exist within the regulated framework.

The relatively low capital intensity implied by the capex figures contrasts with the substantial cash accumulation, raising questions about whether the company is building reserves for future regulatory proceedings or significant capital projects. Without explicit data on regulatory rate case schedules or tracker mechanisms, investors should monitor whether the growing asset base will generate commensurate returns through approved rate increases. The current low ROE of 1.8% suggests any future rate relief may be critical to improving profitability.